Welcome to our dedicated page for HEXO news (Ticker: HEXO), a resource for investors and traders seeking the latest updates and insights on HEXO stock.
HEXO Corp., formerly known as Hydropothecary, is a leading licensed producer and distributor of medical marijuana under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). Dedicated to medical excellence, HEXO excels in advanced cultivation techniques, stringent process controls, quality assurance testing, ongoing research and development, and exceptional customer service.
With a focus on expanding its operations, HEXO is set to add a significant 250,000 square feet greenhouse in 2018 to meet growing demand. The company is constantly seeking talented, energetic, and specialized professionals to join its dynamic team and contribute to the rapidly evolving cannabis industry.
HEXO's product portfolio includes a wide range of medical cannabis products designed to meet the diverse needs of patients. The company is committed to innovation and quality, ensuring that all products meet the highest standards of safety and efficacy.
In recent news, HEXO Corp. has announced key partnerships and strategic initiatives aimed at bolstering its market position and expanding its product offerings. These include collaborations with leading organizations and the introduction of new, innovative products that cater to both the medical and recreational cannabis markets.
Financially, HEXO has shown remarkable growth, reflecting its strong market presence and operational efficiency. The company continues to invest in infrastructure and technology to support its long-term growth strategy and maintain its competitive edge in the industry.
For more information on HEXO Corp.'s latest developments, financial performance, and upcoming projects, visit our news section for the most updated data and insights.
HEXO Corp has signed Purchase and Sale Agreements for its first US production facility in Northern Colorado, spanning approximately 50,000 sq. ft. This facility will enhance HEXO's ability to supply its Powered by HEXO® technology to US consumers and partners, including a joint venture with Molson Coors for CBD-infused beverages. The site is designed for diverse cannabinoid production, complying with all regulations. The transaction is set to close in Q4 2021, pending due diligence and standard conditions.
HEXO Corp. announced a partnership with REQ, a leading digital marketing firm, to boost its expansion in the U.S. market. REQ will serve as HEXO's Agency of Record, assisting in the growth of Truss CBD USA and supporting potential partnerships with non-beverage CPG companies. The collaboration aims to enhance HEXO's brand presence and accelerate its market opportunities. HEXO's CEO highlighted the potential for growth through this partnership, tapping into REQ's expertise in brand management.
HEXO Corp has launched an at-the-market equity program allowing the issuance of up to C$150,000,000 in common shares. These shares will be sold at market prices through the TSX, NYSE, and other exchanges. The program, effective until June 7, 2023, will support general corporate purposes, including U.S. expansion and capital expenditures. The sales will be managed through a distribution agreement with A.G.P./Alliance Global Partners and BMO Capital Markets. The company aims to use proceeds for acquisitions, working capital, and debt repayment related to Zenabis.
OTTAWA, May 7, 2021 – HEXO Corp (TSX: HEXO; NYSE: HEXO) announced that CEO Sebastien St-Louis and CFO Trent MacDonald will present at Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021, at 4:00 p.m. ET. The Company will also hold investor meetings throughout the day. A live webcast of the presentation will be available on the Company’s website. HEXO is a leading cannabis company that distributes products in the Canadian adult-use and medical markets under various brands. For details, visit hexocorp.com.
HEXO Corp has successfully repaid its entire credit facility amounting to approximately $28.9 million as of April 30, 2021. This repayment was made under a credit agreement with Canadian Imperial Bank of Commerce and Bank of Montreal. CEO Sebastien St-Louis stated that this move enhances HEXO's financial flexibility as the company pursues its US expansion plans and aims to be a leading player in Canada’s recreational cannabis market.
HEXO Corp (TSX: HEXO; NYSE: HEXO) announced participation in the Alliance Global Partners 2021 Spring Consumer Cannabis Conference on May 4, 2021. CEO Sebastien St-Louis and CFO Trent MacDonald will represent the Company.
St-Louis will take part in a panel discussing the evolving competitive environment in Canada at 9:00 a.m. ET. Interested individuals can register for a live webcast on the Company’s events page. HEXO is a leading cannabis company known for its innovative products in the Canadian adult-use and medical markets.
HEXO Corp announced that its Masson-Angers cultivation campus has received the Control Union Medical Cannabis Standard GACP certification, establishing it as a leader in medical cannabis cultivation. This certification enhances HEXO's commitment to quality and compliance with World Health Organization guidelines. CEO Sebastien St-Louis emphasized its importance in capturing market share both in Canada and globally.
The CUMCS-GACP certification signifies quality in cannabis propagation, cultivation, and post-harvest processes, promising high standards for partners in the cannabis industry.
HEXO Corp has filed a new preliminary short form base shelf prospectus and a corresponding shelf registration statement with Canadian and U.S. securities regulators. This filing aims to provide HEXO flexibility for strategic initiatives in the U.S. and Canada, as stated by CEO Sebastien St-Louis. The prospectus allows HEXO to offer up to C$1.2 billion in securities over 25 months, which could fund expansion, acquisitions, and general corporate purposes. The filings can be accessed via SEDAR and EDGAR.
HEXO Corp (TSX: HEXO; NYSE: HEXO) has launched a new brand, Bake Sale, aimed at providing affordable cannabis products. The brand offers some of the lowest prices per gram in Canada, with prices up to 20% lower than competitors. Bake Sale is designed for value-conscious consumers and those experimenting with cannabis cooking, featuring products like All Purpose Flower Sativa and Indica in 28 g formats. Initial feedback from provincial boards has been positive, potentially boosting HEXO's market share.
HEXO Corp (TSX: HEXO; NYSE: HEXO) announced that CEO Sebastien St-Louis and CFO Trent MacDonald will engage in a live Q&A at the Wolfe Research Consumer Access Day on March 26, 2021, at 9:15 a.m. ET. The event will be led by Greg Badishkanian and Spencer Hanus. HEXO is a leading cannabis company providing innovative products for the global market, serving both adult-use and medical sectors under various brands. For more details, visit hexocorp.com.
FAQ
What is the market cap of HEXO (HEXO)?
What does HEXO Corp. do?
What recent expansion projects has HEXO undertaken?
What kind of products does HEXO offer?
Has HEXO announced any new partnerships?
What is HEXO's financial outlook?
Where can I find more information about HEXO's latest news?
What regulatory framework does HEXO operate under?
Is HEXO involved in research and development?
What is HEXO's commitment to quality?
How does HEXO contribute to the cannabis industry?
